603351 威尔药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)6.5918.9117.3226.6387.558
总资产报酬率 ROA (%)4.5946.2845.0804.7765.829
投入资产回报率 ROIC (%)4.9606.8185.5835.3696.653

边际利润分析
销售毛利率 (%)28.47928.32327.40927.27728.244
营业利润率 (%)13.15213.29110.53610.19211.490
息税前利润/营业总收入 (%)13.89814.18611.73611.01012.085
净利润/营业总收入 (%)10.97411.1989.4408.5009.608

收益指标分析
经营活动净收益/利润总额(%)94.33692.56797.27393.740100.259
价值变动净收益/利润总额(%)3.1866.9741.186-0.1011.892
营业外收支净额/利润总额(%)-0.256-0.127-0.276-0.336-0.860

偿债能力分析
流动比率 (X)1.2851.2041.0750.8111.099
速动比率 (X)0.9880.8650.7690.5260.762
资产负债率 (%)31.68928.25530.11230.66924.764
带息债务/全部投入资本 (%)24.41320.89022.16421.38012.150
股东权益/带息债务 (%)300.844369.623341.864359.061706.002
股东权益/负债合计 (%)214.706252.993230.891225.738303.217
利息保障倍数 (X)17.82915.5489.54812.91517.436

营运能力分析
应收账款周转天数 (天)56.36054.12852.79843.96334.582
存货周转天数 (天)75.83572.15772.02068.52261.969